http://slideplayer.com/1721745/7/images/31/07%2F09%2F13+Myth%3AThere+is+a+widespread+myth+that+PPARalpha+agonists+do+not+reduce+CV+events+in+diabetics+%28e.g.+primary+analysis+if+FIELD+and+ACCORD%29.jpg